Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Biomarkers Usefulness in the Screening of Hepatocellular Carcinoma in an European High-risk Cohort.

NCT07872319 is registered in ClinicalTrials.gov with Hospital Universitario La Paz as lead sponsor.

NCT NCT07872319
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT07872319 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Biomarkers Usefulness in the Screening of Hepatocellular Carcinoma in an European High-risk Cohort.
Lead sponsor
Hospital Universitario La Paz
Phase
Observational
Overall status
Completed
Start date
February 2, 2022
Completion date
July 31, 2025
Enrollment
417 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

hepatocellular carcinoma (hcc)